Edition:
United States

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

44.55USD
9:45am EST
Change (% chg)

$-0.78 (-1.72%)
Prev Close
$45.33
Open
$44.73
Day's High
$44.73
Day's Low
$44.50
Volume
2,361
Avg. Vol
22,172
52-wk High
$68.91
52-wk Low
$36.66

Select another date:

Thu, Jun 21 2018

Photo

Israel's UroGen to start mid-stage bladder cancer trial

RAANANA, Israel Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.

INTERVIEW-Israel's UroGen to start mid-stage bladder cancer trial

RAANANA, Israel, June 21 Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.

Select another date: